ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.410
+0.120 (9.30%)
At close: Nov 22, 2024, 4:00 PM
1.361
-0.049 (-3.48%)
After-hours: Nov 22, 2024, 6:31 PM EST
ALX Oncology Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 74 | 742 | 459 | 870 | 3,435 | - | |
| Market Cap Growth | -51.47% | 61.50% | -47.23% | -74.66% | - | - | |
| Enterprise Value | -57 | 567 | 181 | 488 | 3,181 | - | |
| Last Close Price | 1.41 | 14.89 | 11.27 | 21.49 | 86.20 | - | |
| PS Ratio | - | - | - | - | 2905.75 | - | |
| PB Ratio | 0.54 | 3.91 | 1.74 | 2.40 | 7.99 | - | |
| P/TBV Ratio | 0.70 | 3.91 | 1.74 | 2.40 | 7.99 | - | |
| EV/Sales Ratio | - | - | - | - | 2691.09 | - | |
| Debt / Equity Ratio | 0.13 | 0.09 | 0.04 | 0.00 | - | -19.64 | |
| Asset Turnover | - | - | - | - | 0.01 | 0.44 | |
| Quick Ratio | 4.63 | 5.08 | 9.40 | 23.78 | 69.99 | 1.92 | |
| Current Ratio | 4.82 | 5.24 | 9.57 | 24.00 | 70.28 | 1.97 | |
| Return on Equity (ROE) | -98.94% | -70.97% | -39.42% | -21.05% | -21.30% | -433.45% | |
| Return on Assets (ROA) | -49.24% | -38.77% | -23.20% | -12.80% | -12.22% | -109.79% | |
| Return on Capital (ROIC) | -59.14% | -44.37% | -25.02% | -13.16% | -12.55% | -167.68% | |
| Earnings Yield | -203.26% | -21.68% | -26.88% | -9.59% | -1.33% | - | |
| FCF Yield | -174.91% | -17.75% | -19.74% | -7.90% | -1.12% | - | |
| Buyback Yield / Dilution | -24.48% | -5.62% | -0.97% | -118.05% | -500.86% | -11.84% | |
| Total Shareholder Return | -24.48% | -5.62% | -0.97% | -118.05% | -500.86% | -11.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.